Biohaven disappointed as rare disease therapy faces FDA setback 'despite promising results'
Venus Remedies expands ASEAN presence with new drug approvals in Vietnam
Relmada gains FDA backing for two registrational trials and reports 92% response with NDV-01 in bladder Cancer
Bristol Myers Squibb prices €5 billion senior unsecured notes offering
Touchlight unveils next-gen circular DNA portfolio for advanced gene therapies
Zydus Lifesciences posts Q2 FY26 PAT at Rs. 1,258.6 Cr
SOUKYA launches Rs. 125 crore, 100-bed AYUSH hospital in Bengaluru
AstraZeneca delivers double-digit growth
Gilead’s Trodelvy falls short on progression-free survival in key breast cancer trial
SMS Pharmaceuticals post Q2 FY26 consolidated PAT at Rs. 25.31 Cr
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes